BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3301244)

  • 1. Bepridil: a new long-acting calcium channel blocking agent.
    Zeller FP; Spinler SA
    Drug Intell Clin Pharm; 1987 Jun; 21(6):487-92. PubMed ID: 3301244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients.
    DiBianco R; Alpert J; Katz RJ; Spann J; Chesler E; Ferri DP; Larca LJ; Costello RB; Gore JM; Eisenman MJ
    Am J Cardiol; 1984 Jan; 53(1):35-41. PubMed ID: 6362386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of bepridil in patients with chronic stable angina pectoris: results of a multicenter, placebo-controlled study of extended bepridil use.
    DiBianco R; Katz RJ; Chesler E; Alpert JS; Spann JF
    Am J Cardiol; 1985 Mar; 55(7):50C-54C. PubMed ID: 3919557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bepridil, a new antianginal agent: clinical and hemodynamic alterations during the treatment of stable angina pectoris.
    Narahara KA; Shapiro W; Weliky I; Park J
    Am J Cardiol; 1984 Jan; 53(1):29-34. PubMed ID: 6419578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
    Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
    Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris.
    Hollingshead LM; Faulds D; Fitton A
    Drugs; 1992 Nov; 44(5):835-57. PubMed ID: 1280569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antianginal effects of bepridil and propranolol in angina pectoris.
    Parker JO; Farrell B
    Am J Cardiol; 1986 Sep; 58(6):449-52. PubMed ID: 3529909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bepridil with nadolol for angina pectoris.
    Pflugfelder PW; Humen DP; O'Brien PA; Purves PD; Jablonsky G; Kostuk WJ
    Am J Cardiol; 1987 Jun; 59(15):1283-8. PubMed ID: 3296724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic actions of bepridil during treatment of stable angina pectoris.
    Narahara KA; Shapiro W; Weliky I; Park J
    Am J Cardiol; 1985 Mar; 55(7):55C-58C. PubMed ID: 3883742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic focus: bepridil].
    Woler C
    Ann Cardiol Angeiol (Paris); 1984; 33(4):245-6. PubMed ID: 6380383
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of bepridil in patients with chronic stable angina: results of a multicenter trial.
    Hill JA; O'Brien JT; Alpert JS; Gore JM; Zusman RM; Christensen D; Boucher CA; Vetrovec G; Borer JS; Friedman C
    Circulation; 1985 Jan; 71(1):98-103. PubMed ID: 3880521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bepridil, a new antianginal agent, on ambulatory electrocardiography in human volunteers.
    Duchêne-Marullaz P; Kantelip JP; Trolèse JF
    J Cardiovasc Pharmacol; 1983; 5(3):506-10. PubMed ID: 6191153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bepridil: a review of its pharmacology and clinical efficacy as an anti-anginal agent with anti-arrhythmic properties.
    Alpert JS; Coumel P; Greeff K; Krikler DM; Remme WJ; Schönbaum E; Verduyn CW
    Pharmatherapeutica; 1985; 4(4):195-222. PubMed ID: 2414784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicardipine, nitrendipine, and bepridil: new calcium antagonists for cardiovascular disorders.
    Hasegawa GR
    Clin Pharm; 1988 Feb; 7(2):97-108. PubMed ID: 3280222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of clinical efficacy and tolerance of bepridil in patients with effort-induced angina pectoris].
    Lai C; Pirisi R; Onnis E; Tallu B; Delogu G; Cherchi A; Arca M; Cherchi A
    Cardiologia; 1985 Jul; 30(7):527-31. PubMed ID: 3914919
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of bepridil for the treatment of angina pectoris: evidence for preservation of left ventricular function.
    Zusman RM; Christensen DM; Kanarek DJ; Kiess MC; Boucher CA
    Am J Cardiol; 1985 Mar; 55(7):30C-35C. PubMed ID: 3919555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term bepridil monotherapy for angina pectoris.
    Sharma MK; Voyles W; Prasad R; Teague SM; Thadani U
    Am J Cardiol; 1988 Jun; 61(15):1210-3. PubMed ID: 3287882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinical efficacy of bepridil, propranolol and placebo in patients with chronic stable angina.
    Rae AP; Beattie JM; Lawrie TD; Hutton I
    Br J Clin Pharmacol; 1985 Mar; 19(3):343-52. PubMed ID: 3885985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of calcium antagonists.
    Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
    Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bepridil versus verapamil in stable angina pectoris--a controlled clinical trial.
    Nielsen HK; Krusell LR; Husted SE; Pluymers RJ
    Int J Cardiol; 1989 Jun; 23(3):357-64. PubMed ID: 2500401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.